- Home
- TNXP vs HFFG Comparison
TNXP vs HFFG Comparison
Compare TNXP & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- HFFG
- Stock Information
- Founded
- TNXP 2007
- HFFG 1997
- Country
- TNXP United States
- HFFG United States
- Employees
- TNXP N/A
- HFFG N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- HFFG Food Distributors
- Sector
- TNXP Health Care
- HFFG Consumer Discretionary
- Exchange
- TNXP Nasdaq
- HFFG Nasdaq
- Market Cap
- TNXP 116.9M
- HFFG 100.2M
- IPO Year
- TNXP N/A
- HFFG N/A
- Fundamental
- Price
- TNXP $15.71
- HFFG $3.92
- Analyst Decision
- TNXP Strong Buy
- HFFG
- Analyst Count
- TNXP 2
- HFFG 0
- Target Price
- TNXP $585.00
- HFFG N/A
- AVG Volume (30 Days)
- TNXP 1.5M
- HFFG 320.9K
- Earning Date
- TNXP 05-12-2025
- HFFG 05-07-2025
- Dividend Yield
- TNXP N/A
- HFFG N/A
- EPS Growth
- TNXP N/A
- HFFG N/A
- EPS
- TNXP N/A
- HFFG N/A
- Revenue
- TNXP $10,094,000.00
- HFFG $1,201,667,000.00
- Revenue This Year
- TNXP $12.17
- HFFG $4.77
- Revenue Next Year
- TNXP $789.15
- HFFG $3.97
- P/E Ratio
- TNXP N/A
- HFFG N/A
- Revenue Growth
- TNXP 29.94
- HFFG 4.63
- 52 Week Low
- TNXP $6.76
- HFFG $1.70
- 52 Week High
- TNXP $672.00
- HFFG $4.93
- Technical
- Relative Strength Index (RSI)
- TNXP 44.80
- HFFG 53.69
- Support Level
- TNXP $15.23
- HFFG $3.87
- Resistance Level
- TNXP $22.25
- HFFG $4.18
- Average True Range (ATR)
- TNXP 2.36
- HFFG 0.43
- MACD
- TNXP -0.54
- HFFG -0.11
- Stochastic Oscillator
- TNXP 16.54
- HFFG 17.89
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.